title: Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Allegra
authors.forename: Allegra
authors.initials: A
authors.lastname: Alessandro
authors.forename: Andrea
authors.initials: A
authors.lastname: Alonci
authors.forename: Giacomo
authors.initials: G
authors.lastname: Bellomo
authors.forename: Eugenia
authors.initials: E
authors.lastname: Quartarone
authors.forename: Arianna
authors.initials: A
authors.lastname: D'Angelo
authors.forename: Patricia
authors.initials: P
authors.lastname: Rizzotti
authors.forename: Angela
authors.initials: A
authors.lastname: Granata
authors.forename: Musolino
authors.initials: M
authors.lastname: Caterina
mesh_terms: D000368:Aged; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002999:Clone Cells / Q000473:pathology; D005260:Female; D006801:Humans; D015458:Leukemia, T-Cell / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D014740:Vidarabine; C024352:fludarabine